| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192580 | Annals of Allergy, Asthma & Immunology | 2009 | 6 Pages |
Abstract
3-Bromotyrosine and 3,5-dibromotyrosine levels reflect treatment effects in asthma and support previous findings that SABAs impair the anti-inflammatory effects of inhaled corticosteroids. In addition to eosinophil numbers and eosinophil cationic protein levels, these modified tyrosine residues provide useful information about the inflammatory state of the airways.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Christine J. PhD, MBChB, Ruth E. MD, Timothy MSc, Revathy PhD, Robert J. MD, Jan O. Cowan, D. Robin MD, G. Ian MD, Anthony J. PhD,